Biogen, Eisai say injectable Alzheimer’s therapy granted FDA review
Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALF) (OTCPK:ESAIY) announced that the U.S. Food and Drug Administration (FDA) ...
Alzheimer’s drugs eyed as next big obesity-like opportunity
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Rolling Out1d
New virus discovery may unlock Alzheimer’s mystery
Groundbreaking research unveils potential link between cytomegalovirus and Alzheimer's disease, offering new hope for ...
New dementia tool predicts when symptoms will start: ‘Would you want to know?’
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
Dementia risk may be twice as high as Americans live longer, study finds
Older studies estimated a lower risk of dementia. According to new research, the number of people living with the disease in ...
Rolling Out8d
Dopamine’s surprising breakthrough in Alzheimer’s treatment
Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...
StudyFinds on MSN10d
How Alzheimer’s disease may be sparked by the herpes virus
Discover the surprising link between herpes and Alzheimer's disease. Find out how the common herpes simplex virus may play a ...
Medical News Today5d
Is Alzheimer's linked to the cold-sore-causing herpes virus?
There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...